NeueHealth (NYSE:NEUE) Stock Price Down 0.1% – Should You Sell?

NeueHealth, Inc. (NYSE:NEUEGet Free Report)’s share price traded down 0.1% during mid-day trading on Tuesday . The company traded as low as $6.62 and last traded at $6.70. 8,338 shares traded hands during trading, an increase of 44% from the average session volume of 5,775 shares. The stock had previously closed at $6.71.

NeueHealth Stock Down 0.1%

The firm has a market capitalization of $60.43 million, a price-to-earnings ratio of -0.42 and a beta of 0.58. The company’s 50 day moving average price is $6.72 and its 200 day moving average price is $6.67.

NeueHealth (NYSE:NEUEGet Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported ($1.68) EPS for the quarter, topping analysts’ consensus estimates of ($4.77) by $3.09. The firm had revenue of $209.08 million for the quarter, compared to analyst estimates of $249.50 million. As a group, analysts expect that NeueHealth, Inc. will post -9.13 earnings per share for the current year.

Institutional Trading of NeueHealth

Several institutional investors have recently bought and sold shares of the business. PenderFund Capital Management Ltd. purchased a new stake in NeueHealth in the 1st quarter worth $197,000. Skandinaviska Enskilda Banken AB publ purchased a new stake in NeueHealth during the 2nd quarter worth approximately $201,000. Finally, Northern Trust Corp raised its holdings in shares of NeueHealth by 66.8% during the fourth quarter. Northern Trust Corp now owns 32,644 shares of the company’s stock valued at $242,000 after acquiring an additional 13,074 shares during the last quarter. 63.88% of the stock is owned by institutional investors and hedge funds.

About NeueHealth

(Get Free Report)

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.

Read More

Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.